Notably, Wejksza et al. demonstrated that induction of tBregs required the activation of 5-LO in the B-cells, not just the cancer cells, as specific inhibitors of the 5-LO pathway completely abrogated this process. The gene discussed is ALOX5; the disease is cancer.